Colorectal cancer treatment (CRC)

Colorectal cancer treatment (CRC)

Julie Scott, DNP
Julie Scott, DNP

Treatment is often classified into local therapy or systemic therapy. Local therapy means that it only treats the colon or rectum, and not any other parts of the body. Systemic therapy is treatment that goes around your entire body, treating cancer cells that may be present outside of the colon. A combination of local and systemic therapy may be given for CRC. 

This article will focus on the systemic therapy options for CRC- chemotherapy, targeted therapy, and immunotherapy.

Chemotherapy 

Chemotherapy is medication that is used to stop the division of cells, causing cell death. Because cancer cells are abnormal and usually grow out of control, they are killed by chemotherapy. Unfortunately, chemotherapy can cause side effects because healthy cells are affected as well.

Chemotherapy can be given before surgery (called neoadjuvant chemo) or after surgery (adjuvant chemo). 

To treat CRC, a combination of multiple chemotherapy medications are often given. These work against the cancer cells in different ways, so that the cancer is being killed more effectively. The chemotherapy medications used most often to treat CRC include:

  • 5-fluorouracil (5-FU)
  • Oxaliplatin
  • Capecitabine (Xeloda)

If cancer has spread to other areas of the body, different chemotherapy medications may be given. 

Targeted Therapy

These medications are usually only given if colon cancer is advanced and has spread into other areas of the body. If the cancer has specific genetic mutations, such as mutations in the KRAS or BRAF genes, there may be medications available that target those genes specifically. 

Immunotherapy

Immunotherapy medications are usually intravenous medications that work by helping the immune system see any CRC cells in the body. This allows the immune system to help fight against cancer. Immunotherapy medications are most often used for advanced CRC.

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
Desmoplastic Small Round Cell Tumors (DSRCT): Causes, Symptoms and Treatment Options
January 23, 2023

What are Desmoplastic Small Round Cell Tumors? Desmoplastic small round cell tumors (DSRCTs) are a rare and aggressive type of soft tissue sarcoma. The tumors typically develop in the abdomen and can spread to other body parts, such as the lungs, liver, and lymph nodes. DSRCTs are often difficult to…

Julie Scott, DNP

author

Articles
Polycythemia vera
March 1, 2023

What is Polycythemia vera? Polycythemia vera (PV) is a rare type of blood cancer that causes an overproduction of red blood cells in the bone marrow. This results in the thickening of the blood, which can lead to an increased risk of blood clots, stroke, and heart attack. PV is…

Julie Scott, DNP

author

Articles
Understanding Medulloblastoma – Causes, Symptoms, and Treatments Explained
January 23, 2023

What is Medulloblastoma? Medulloblastoma is a type of cancerous brain tumor. It is a tumor that grows quickly in the cerebellum, which is the part of the brain that controls balance and coordination. Medulloblastoma is most commonly found in children, but adults can experience this as well. Symptoms The symptoms…

Julie Scott, DNP

author

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice